Molecular docking revealed that compounds 5, 8, 9, 14, 15 may be the major active ingredients of I. obliquus for the treatment of diabetes, and their antihyperglycemic effect may be mediated, at least in part, by inhibition of DPP-4 activity. This evidence concerns the gene DPP4 and diabetes mellitus.